CDH2 and cancer: Intriguingly, downregulation of epithelial markers such as E-Cadherin and upregulation of mesenchymal markers such as N-Cadherin is seen in epithelial-mesenchymal transition (EMT), a crucial process activated in cancer and generating cells with stem cell properties [89].